Westlake prices $500 million senior unsecured notes

Westlake prices $500 million of senior unsecured notes

6:34 AM, 15th November 2017
Westlake Chemical logo

HOUSTON, US: Westlake Chemical Corporation (WLK) said that it has priced it's previously announced underwritten public offering of $500.0 million aggregate principal amount of senior unsecured notes due 2047. The notes will bear interest at a rate of 4.375 percent per annum and will mature on 15 November 2047. The sale of the notes is scheduled to close on 28 November 2017.

Merrill Lynch, Pierce, Fenner & Smith Incorporated, Deutsche Bank Securities Inc, Goldman Sachs & Co LLC and Wells Fargo Securities LLC are acting as book-running managers for the offering of the notes.

© Worldofchemicals News 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


AkzoNobel opens first application training centre in Dubai

AMSTERDAM, NETHERLANDS: AkzoNobel NV has opened its first regional application training centre in Dubai, further strengthening its customer service st ...

Read more
Shell increases sell down of shares in Woodside Petroleum

THE HAGUE, NETHERLANDS: Royal Dutch Shell plc (Shell) confirms that, following strong demand from institutional investors, Shell Energy Holdings Austr ...

Read more
Clariant to supply sorbents for RTI desulfurization process

MUNICH, GERMANY: Clariant has signed a global licensing agreement to supply their solid sorbent material for RTI International’s warm gas desulf ...

Read more
Lanxess India expands its CSR thrust in Nagda

NAGDA, INDIA: Lanxess India Private Limited has taken another major step towards creating a sustainable environment in & around Nagda, Madhya Prad ...

Read more
Westlake announces public offering of senior notes

HOUSTON, US: Westlake Chemical Corporation (WLK) (“Westlake”) announced the beginning of an underwritten public offering of senior unsecur ...

Read more
Hikma acquires six products from Boehringer for €3 million

LONDON, UK: Hikma Pharmaceuticals PLC (Hikma) has acquired six products from Boehringer Ingelheim GmbH (Boehringer Ingelheim), for an aggregate consid ...

Read more